How a public exhibit led to the 1938 Food, Drug, and Cosmetic Act
Building a foundation for FDA compliance
IT and collaboration key to efforts
Fast-track program evaluates brain implants for the blind
A document management system is now a compliance best practice
The least burdensome approach
More than 500 experts convene at summit in Kyoto, Japan
Overcoming stress at work, the benefits of AS9100, and meaningless food labels
Consumers will become ever-more mystified about what’s on a label
The most important lessons I’ve learned in pharmaceutical quality assurance during the last 40 years
Cost-cutting at Ford, compassionate-use drugs, and innovation stagnation
FDA recognizes that time is critical for seriously ill patients who do not have alternative therapies
All technology, all the time
What’s the difference?
Physical well-being and confidentiality depend on it
Public dockets will solicit feedback from patients, consumers, health providers, and state governments
In oncology drug development, government, regulatory medicine, and cancer advocacy
Self-climbing stairs, after-sales service, and can you be too concerned about quality?
FDA warning letters indicate the agency continues to be concerned about noncompliance
A plan for digital health devices
